In Case You Missed It: Three Things we Learned in our Dealmaking Trends Webinar

Evaluate's recent webinar, "Licence Drivers: Trends in Pharma Dealmaking," explored critical aspects of market analysis and strategic partnerships, offering insights whose core lessons resonate far beyond the pharmaceutical sector. For senior decision-makers in the construction industry, the discussion, which featured experts from Novartis and Insmed, underscores the universal imperative of leveraging robust data to inform strategic actions in an increasingly complex environment. The webinar highlighted the vital importance of identifying market trends, assessing competitive intensity, and evaluating potential partners—principles directly applicable to optimising project pipelines, forging strategic alliances, and navigating a dynamic construction landscape. Understanding commercial differentiation and maintaining a comprehensive view of the competitive environment are presented as non-negotiable for informed investment and commercial strategy. In a sector marked by evolving regulations, material costs, and technological advancements, the ability to conduct systematic candidate comparisons based on robust criteria is paramount. This proactive, intelligence-driven approach, exemplified by Evaluate’s methodology, equips construction leaders to anticipate market shifts, prioritise opportunities, and navigate the inherent risk and reward potential of every decision. Such analytical rigour is essential for securing a decisive competitive edge, ensuring strategic resilience and growth. Read More